Skip to main content
  • Proff Kaleebu Named Among The Top CEOs In Uganda

    Proff Kaleebu Pontiano  has been named as one of the top CEOs in Uganda.  Prof. Kaleebu is the Executive Director of the Uganda Virus Research Institute and oversees the activities of the EACCR secretariat and the entire network. He also chairs the Project Implementation Committee (PIC) which holds teleconferences every quarter.

    Read more details here

  • Treatment Protocols and approaches from different countries: The African Story

    The Global Health Network in partnership with the Uganda Virus Research Institute are bringing together experts across Africa to share their experiences on Treatment Protocols.

    This event will focus on approaches for different countries, exploring the challenges/successes/barriers to implementation of such research studies. Participants will understand how African countries are reacting to the Coronavirus pandemic and how they are concurrently researching the gaps that need urgent attention.


    A successful HIV response requires increased contribution to the research efforts by those countries and regions that are hardest hit by the epidemic. Sub-Saharan Africa remains the region most severely affected, with 25 million adults and children living with HIV and AIDS. The contribution of multiple sectors in different countries in Africa to the HIV response cannot be understated.

  • The Tenth EDCTP Forum call for abstracts (oral and poster presentations)

    The EDCTP Forum is a biennial event that provides an international platform for the presentation and discussion of cutting-edge research addressing the burden of poverty-related infectious diseases in sub-Saharan Africa and the capacity development and networking activities that support this goal.

    The EDCTP Forum attracts a diverse audience, including representatives from research institutions and universities, the larger scientific community, health care providers, governments, regional bodies, regulators, civil society, and public and private research and development partners.